CanadaBis Capital (TSXV:CANB) Research & Development: C$0.00 Mil (TTM As of Oct. 2025)


What is CanadaBis Capital Research & Development?

CanadaBis Capital TSXV:CANB Research & Development is C$0.00 Mil as of Oct. 2025. The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. CanadaBis Capital's Research & Development for the three months ended in Oct. 2025 was C$0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Oct. 2025 was C$0.00 Mil.

CanadaBis Capital  (TSXV:CANB) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

CanadaBis Capital Research & Development Related Terms

CanadaBis Capital Research & Development Historical Data

* Premium members only.

The historical data trend for CanadaBis Capital's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CanadaBis Capital Research & Development Chart

CanadaBis Capital Annual Data
Trend Nov16 Dec17 Dec18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CanadaBis Capital Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CanadaBis Capital Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Oct. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of C$0.00 Mil mean?
CanadaBis Capital (TSXV:CANB) has a Research & Development of C$0.00 Mil as of Oct. 2025. Research and development expense is the total cost for research and development activities. View historical data on CanadaBis Capital and its competitors.
Is CanadaBis Capital's Research & Development too high?
CanadaBis Capital's current Research & Development is C$0.00 Mil.
How does CanadaBis Capital's Research & Development compare to ZTS?
CanadaBis Capital's Research & Development of C$0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on CanadaBis Capital and its competitors. CanadaBis Capital's current Research & Development is C$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CanadaBis Capital stock overvalued right now?
CanadaBis Capital (TSXV:CANB) has a current Research & Development of C$0.00 Mil. The stock's GF Value™ is C$0.07, compared to a current price of C$0.02 — trading 78.6% below its estimated fair value. The current Research & Development is C$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For CanadaBis Capital (TSXV:CANB), the current Research & Development is C$0.00 Mil as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CanadaBis Capital Business Description

Other Exchanges CNADF:USA
Address 255C Clearview Drive, Red Deer County, Red Deer, AB, CAN, T4E 3B6
CanadaBis Capital Inc is a vertically integrated cannabis company. The firm engages in the production and sale of recreational cannabis. Its product line consists of Stigma Roots. It operates in three segments: wholesale, retail, and extract. The wholesale segment cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards. Retail segment involves sale of cannabis and cannabis-related products to end consumers on-premises owned and operated by the Company. Extract segment provides cannabinoid extraction services to other licensed producers. The company generates maximum of its revenue from Extract Segment.